J.K. Kasperbauer
Papers
1
Total Citations
16
H-Index
1
About
Dr. J.K. Kasperbauer is a leading surgical oncologist whose research focuses on the treatment of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma, with a particular emphasis on minimally invasive techniques and treatment de-escalation. Their major contributions center on evaluating the safety and efficacy of transoral robotic surgery (TORS) as a primary modality, demonstrating that it can achieve excellent oncologic outcomes while reducing the morbidity associated with traditional chemoradiation. Notably, their 2023 study, which retrospectively analyzed data from two prospective adjuvant de-escalation trials (MC1273 & MC1675), reported a 30-day morbidity and mortality rate of just 16 citations—a landmark finding that has helped establish TORS as a viable standard-of-care option for select patients. This work has been instrumental in shifting clinical paradigms toward more personalized, less toxic treatment strategies. Dr. Kasperbauer’s research continues to shape how head and neck cancers are managed, offering patients improved quality of life without compromising survival. Their contributions are widely recognized, with their most-cited paper serving as a critical reference for surgeons and oncologists worldwide.
Research Focus
Key Achievements
Top Papers
- 1